Jinhe Biotechnology Co Ltd (002688) — Net Asset Quality Index
Jinhe Biotechnology Co Ltd (002688) has a Net Asset Quality Index of 46.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.58 Billion minus total liabilities of CN¥2.99 Billion yields net assets of CN¥2.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002688 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jinhe Biotechnology Co Ltd Net Asset Quality Index Over Time (2008–2024)
This chart shows how Jinhe Biotechnology Co Ltd's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the index stands at 46.5%, representing net assets of CN¥2.60 Billion against total assets of CN¥5.58 Billion CNY. Explore cash efficiency ratio of Jinhe Biotechnology Co Ltd to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Jinhe Biotechnology Co Ltd (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Jinhe Biotechnology Co Ltd from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Jinhe Biotechnology Co Ltd (002688) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 44.2% | CN¥2.50 Billion | CN¥5.65 Billion | CN¥3.15 Billion | ▼ -1.9 pp |
| 2023 | 46.1% | CN¥2.52 Billion | CN¥5.45 Billion | CN¥2.94 Billion | ▼ -7.7 pp |
| 2022 | 53.8% | CN¥2.43 Billion | CN¥4.51 Billion | CN¥2.08 Billion | ▼ -12.5 pp |
| 2021 | 66.3% | CN¥2.70 Billion | CN¥4.06 Billion | CN¥1.37 Billion | ▲ +14.5 pp |
| 2020 | 51.8% | CN¥1.75 Billion | CN¥3.38 Billion | CN¥1.63 Billion | ▼ -2.2 pp |
| 2019 | 54.0% | CN¥1.81 Billion | CN¥3.34 Billion | CN¥1.54 Billion | ▲ +0.7 pp |
| 2018 | 53.3% | CN¥1.78 Billion | CN¥3.34 Billion | CN¥1.56 Billion | ▼ -2.0 pp |
| 2017 | 55.3% | CN¥1.64 Billion | CN¥2.96 Billion | CN¥1.32 Billion | ▼ -4.2 pp |
| 2016 | 59.5% | CN¥1.58 Billion | CN¥2.66 Billion | CN¥1.08 Billion | ▲ +3.6 pp |
| 2015 | 55.9% | CN¥1.05 Billion | CN¥1.89 Billion | CN¥830.68 Million | ▼ -7.0 pp |
| 2014 | 63.0% | CN¥956.13 Million | CN¥1.52 Billion | CN¥562.50 Million | ▼ -25.6 pp |
| 2013 | 88.5% | CN¥900.07 Million | CN¥1.02 Billion | CN¥116.81 Million | ▲ +2.4 pp |
| 2012 | 86.1% | CN¥863.55 Million | CN¥1.00 Billion | CN¥139.83 Million | ▲ +36.2 pp |
| 2011 | 49.8% | CN¥334.40 Million | CN¥670.84 Million | CN¥336.44 Million | ▲ +9.0 pp |
| 2010 | 40.8% | CN¥254.83 Million | CN¥623.92 Million | CN¥369.09 Million | ▲ +9.2 pp |
| 2009 | 31.7% | CN¥196.03 Million | CN¥618.59 Million | CN¥422.56 Million | ▲ +0.3 pp |
| 2008 | 31.4% | CN¥177.82 Million | CN¥566.45 Million | CN¥388.63 Million | — |